AMD's AI-driven momentum, Constellation Energy's nuclear growth strategy and Freeport-McMoRan's copper outlook headline today ...
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Exelixis (EXEL) or Exact Sciences (EXAS). But which of these two stocks offers value ...
Exel has entered into a new purchasing agreement with global resin specialist Polynt to purchase hundreds of tonnes of its bio-based unsaturated polyester resin (UPR). The collaboration represents ...
Each startup receives $300,000, increasing the total investment due to the larger group. Selected studios gain mentorship and hands-on support from global industry leaders. Applications for Cohort 3 ...
Exelixis is positioned for growth with positive phase 3 data for zanzalintinib in metastatic colorectal cancer, following cabozantinib's success. STELLAR-303 results show modest survival benefit but ...
Nick Van Exel was one of those who had the privilege of being Kobe Bryant's teammate during his career, so he witnessed the Mamba Mentality everyone spoke about as Kobe was only growing his legend in ...
Startups unveiled original IP rooted in Saudi stories but built for global markets. Merak Capital’s $80m Gaming Fund powers the accelerator’s long-term vision. Exel provides equity investment, ...
EXEL continues to grow cabozantinib revenues while advancing zanzalintinib, but recent trial updates have been mixed and market reaction muted. STELLAR-303 has produced a success for zanzalintinib, ...
This partnership combines Exel’s 40 years of ERP expertise with Comparesoft’s intelligent matching engine to help businesses in sectors like aerospace, automotive, engineering, and construction find ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results